Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Wrenger

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Aptamer Applications in Emerging Viral DiseasesArne Krüger, Ana Paula de Jesus Santos, Vanessa de Sá, et al.
Acta Crystallographica. Section F, Structural Biology Communications|July 6, 2016
Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparumSergey Lunev, Soraya S Bosch, Fernando de Assis Batista, et al.
Biological Chemistry|November 30, 2006
The human malaria parasite Plasmodium falciparum expresses an atypical N-terminally extended pyrophosphokinase with specificity for thiamineMarie-Luise Eschbach, Ingrid B Müller, Tim-Wolf Gilberger, et al.
Current Pharmaceutical Design|July 2, 2011
The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas diseasePaes Lisvane Silva, Brian Suárez Mantilla, Maria Julia Barisón, et al.
Molecular and Biochemical Parasitology|December 11, 2007
Filling the gap of intracellular dephosphorylation in the Plasmodium falciparum vitamin B1 biosynthesisJulia Knöckel, Bärbel Bergmann, Ingrid B Müller, et al.
Chemical Biology & Drug Design|October 16, 2018
Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screeningKamila Anna Meissner, Thales Kronenberger, Vinícius Gonçalves Maltarollo, et al.
Frontiers in Cellular and Infection Microbiology|June 28, 2021
Targeting SUMOylation in <i>Plasmodium</i> as a Potential Target for Malaria TherapyDaffiny Sumam de Oliveira, Thales Kronenberger, Giuseppe Palmisano, et al.
Biomed Research International|August 19, 2014
Harnessing the helminth secretome for therapeutic immunomodulatorsDana Ditgen, Emmanuela M Anandarajah, Kamila A Meissner, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 12, 2012
Crystallization and preliminary X-ray diffraction of malate dehydrogenase from Plasmodium falciparumCarsten Wrenger, Ingrid B Müller, Sabine Butzloff, et al.
The Biochemical Journal|January 17, 2012
The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interferenceJulia Knöckel, Ingrid B Müller, Sabine Butzloff, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Aptamer Applications in Emerging Viral DiseasesArne Krüger, Ana Paula de Jesus Santos, Vanessa de Sá, et al.
Acta Crystallographica. Section F, Structural Biology Communications|July 6, 2016
Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparumSergey Lunev, Soraya S Bosch, Fernando de Assis Batista, et al.
Biological Chemistry|November 30, 2006
The human malaria parasite Plasmodium falciparum expresses an atypical N-terminally extended pyrophosphokinase with specificity for thiamineMarie-Luise Eschbach, Ingrid B Müller, Tim-Wolf Gilberger, et al.
Current Pharmaceutical Design|July 2, 2011
The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas diseasePaes Lisvane Silva, Brian Suárez Mantilla, Maria Julia Barisón, et al.
Molecular and Biochemical Parasitology|December 11, 2007
Filling the gap of intracellular dephosphorylation in the Plasmodium falciparum vitamin B1 biosynthesisJulia Knöckel, Bärbel Bergmann, Ingrid B Müller, et al.
Chemical Biology & Drug Design|October 16, 2018
Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screeningKamila Anna Meissner, Thales Kronenberger, Vinícius Gonçalves Maltarollo, et al.
Frontiers in Cellular and Infection Microbiology|June 28, 2021
Targeting SUMOylation in <i>Plasmodium</i> as a Potential Target for Malaria TherapyDaffiny Sumam de Oliveira, Thales Kronenberger, Giuseppe Palmisano, et al.
Biomed Research International|August 19, 2014
Harnessing the helminth secretome for therapeutic immunomodulatorsDana Ditgen, Emmanuela M Anandarajah, Kamila A Meissner, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 12, 2012
Crystallization and preliminary X-ray diffraction of malate dehydrogenase from Plasmodium falciparumCarsten Wrenger, Ingrid B Müller, Sabine Butzloff, et al.
The Biochemical Journal|January 17, 2012
The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interferenceJulia Knöckel, Ingrid B Müller, Sabine Butzloff, et al.
Pageof 11